These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4151686)

  • 21. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 22. [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
    Masumoto S; Inoue H; Maruyama Y
    Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):517-25. PubMed ID: 44259
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol hydrochloride (YB-2) on coronary circulation and and myocardial metabolism].
    Takenaka F; Ishihara T; Higuchi M; Hiraki I; Kawagoe T
    Nihon Yakurigaku Zasshi; 1972 Nov; 68(6):848-56. PubMed ID: 4144773
    [No Abstract]   [Full Text] [Related]  

  • 24. [The pharmacology of (+/-)-1-(4-cyclohexylureido-phenoxy)-2-hydroxy-3-tert-butylaminopropane (Talinolol, Cordanum, 02-115)].
    Femmer K; Bartsch R; Leonhardt U; von Littrow C; Riedel H
    Pharmazie; 1975 Oct; 30(10):642-51. PubMed ID: 688
    [No Abstract]   [Full Text] [Related]  

  • 25. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of Kö 1366 on the distribution of intrarenal blood flow in normal canine kidneys.
    Nakamura M; Nose Y; Tomoike H; Shirai T; Kuroiwa A
    Arzneimittelforschung; 1974 Sep; 24(9):1325-8. PubMed ID: 4154766
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative study of beta-adrenoceptor blocking efficacy of two formulations of esmolol in vivo and in vitro.
    Tripathi CB; Bhattacharya P; Bhatt JD; Hemavathi KG
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):255-8. PubMed ID: 10365322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs].
    Mazurowa A; Szadowska A; Szmigielski A
    Kardiol Pol; 1972; 15(2):167-75. PubMed ID: 4403276
    [No Abstract]   [Full Text] [Related]  

  • 30. Local anaesthetic and myocardial depressant effects of beta adrenoceptor blocking agents.
    Singh KP
    Indian J Physiol Pharmacol; 1980; 24(2):161-2. PubMed ID: 6103869
    [No Abstract]   [Full Text] [Related]  

  • 31. [Atypical dose-frequency relation as characteristic of a beta receptor blocker].
    Klempt HW; Müller WD; Bender F
    Verh Dtsch Ges Inn Med; 1973; 79():1015-8. PubMed ID: 4151337
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiarrhythmic activity of 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Takagi K
    Jpn J Pharmacol; 1974 Aug; 24(4):589-9. PubMed ID: 4455968
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-adrenergic blockade by 3-[3-(substituted amino)-2-hydroxypropox]-5-hydroxybenzyl alcohols.
    Schwender CF; Pike RE; Shavel J
    J Med Chem; 1975 Feb; 18(2):211-3. PubMed ID: 235645
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124].
    Fujita T; Miyazaki M
    Masui; 1972 May; 21(5):450-7. PubMed ID: 4403862
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-arrhythmic and beta-adrenoceptor blocking activities of vanilol (author's transl)].
    Pan XX; Xiao JG; Lu YZ; Liu TP
    Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):97-101. PubMed ID: 6121452
    [No Abstract]   [Full Text] [Related]  

  • 37. [Quantitative structure activity relationships of phenylakylamines. 2. Discrimination analysis of adrenergic alpha, anti-arrhythmic and cardiodepressive effects of beta receptor blockers (proceedings)].
    Bercher H; Laass W; Schult E; Grisk A; Franke R
    Pharmazie; 1979; 34(5-6):336-7. PubMed ID: 42092
    [No Abstract]   [Full Text] [Related]  

  • 38. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
    Madan BR; Vyas DS
    Indian J Physiol Pharmacol; 1973; 17(3):227-34. PubMed ID: 4151008
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ; Harting J
    J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.